Literature DB >> 3522450

Lack of thermogenic response to glucose/insulin infusion in diabetic obese subjects.

A Golay, Y Schutz, J P Felber, R A de Fronzo, E Jéquier.   

Abstract

The change in energy expenditure consecutive to the infusion of glucose/insulin was examined in 17 non-obese (ten young, seven middle-aged) and 27 diabetic and non-diabetic obese subjects by employing the euglycemic insulin clamp technique in conjunction with continuous indirect calorimetry. The obese subjects were divided into four groups according to their response to a 100-g oral glucose test: group A, normal glucose tolerance; group B, impaired glucose tolerance; group C, diabetes with increased insulin response; group D, diabetes with reduced insulin response. The glucose/insulin infusion provoked an increase in energy expenditure in both young and middle-aged controls (+8.2 +/- 1.3 percent and +5.9 +/- 0.5 percent over the preinfusion baseline respectively), but a lower increase in the non-diabetic obese groups A and B (+4.0 +/- 0.7 percent and +2.0 +/- 1.0 percent over the preinfusion baseline respectively, P less than 0.05 and P less than 0.01 vs young controls). However, in the diabetic obese groups C and D, energy expenditure failed to increase in response to the glucose/insulin infusion (mean change: +0.1 +/- 1.0 percent and -2.0 +/- 1.9 percent (P less than 0.01, vs middle-aged) over the preinfusion baseline respectively). When the glucose-induced thermogenesis (GIT) was related to the glucose uptake--taking into account the hepatic glucose production--the GIT was found to be similarly reduced in the diabetics groups (C and D). The net change in the rate of energy expenditure was found to be significantly correlated with the rate of glucose uptake (r = +0.647, n = 44, P less than 0.001) when all the individuals were pooled. In conclusion, this study shows that the low glucose-induced thermogenesis in obese diabetics during glucose insulin infusion is mainly related to a reduced rate of glucose uptake; in addition, inhibition of gluconeogenesis by the glucose/insulin infusion may also contribute to decrease the thermogenic response.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3522450

Source DB:  PubMed          Journal:  Int J Obes


  7 in total

1.  Ex vivo and in vivo evaluation of the norepinephrine transporter ligand [11C]MRB for brown adipose tissue imaging.

Authors:  Shu-fei Lin; Xiaoning Fan; Catherine Weikart Yeckel; David Weinzimmer; Tim Mulnix; Jean-Dominique Gallezot; Richard E Carson; Robert S Sherwin; Yu-Shin Ding
Journal:  Nucl Med Biol       Date:  2012-05-16       Impact factor: 2.408

Review 2.  Expenditure and storage of energy in man.

Authors:  E A Sims; E Danforth
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

3.  Carbohydrate-induced thermogenesis in obese women. Effect of insulin and catecholamines.

Authors:  L Van Gaal; I Mertens; G Vansant; I De Leeuw
Journal:  J Endocrinol Invest       Date:  1999-02       Impact factor: 4.256

4.  Independent effects of obesity and insulin resistance on postprandial thermogenesis in men.

Authors:  K R Segal; J Albu; A Chun; A Edano; B Legaspi; F X Pi-Sunyer
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

5.  Factors associated with basal metabolic rate in patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  A Franssila-Kallunki; L Groop
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

6.  Twenty-four-hour energy expenditure in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  A M Fontvieille; S Lillioja; R T Ferraro; L O Schulz; R Rising; E Ravussin
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

7.  Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.

Authors:  Nora E Straznicky; Mariee T Grima; Carolina I Sari; Nina Eikelis; Elisabeth A Lambert; Paul J Nestel; Murray D Esler; John B Dixon; Reena Chopra; Alan J Tilbrook; Markus P Schlaich; Gavin W Lambert
Journal:  Diabetes       Date:  2012-06-04       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.